Table of Content


Chapter 1. Global Coronary Artery Bypass Graft Devices Market Executive Summary
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Method
?1.3.2. By Surgical Procedure
?1.3.3. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Coronary Artery Bypass Graft Devices Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply-Side Analysis
??2.3.3.1. Infrastructure & Capacity
??2.3.3.2. Regulatory Environment
??2.3.3.3. Market Competition
??2.3.3.4. Economic Viability (Provider’s Perspective)
?2.3.4. Demand-Side Analysis
??2.3.4.1. Cardiovascular Disease Burden
??2.3.4.2. Surgical Adoption Trends
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Coronary Artery Bypass Graft Devices Market Dynamics
3.1. Market Drivers
?3.1.1. Rising Prevalence of Coronary Artery Disease
?3.1.2. Technological Advances in Minimally Invasive Techniques
?3.1.3. Shift to Value-Based and Patient-Centric Care Models
3.2. Market Challenges
?3.2.1. High R&D and Regulatory Approval Costs
?3.2.2. Shortage of Skilled Cardiothoracic Surgeons
?3.2.3. Reimbursement and Cost-Containment Pressures
3.3. Market Opportunities
?3.3.1. Development of Precision and Patient-Specific Grafts
?3.3.2. Integration of AI and Robotics in Surgical Planning
?3.3.3. Expansion into Emerging and Underserved Markets
Chapter 4. Global Coronary Artery Bypass Graft Devices Market Industry Analysis
4.1. Porter’s Five Forces
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Winning Market Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Coronary Artery Bypass Graft Devices Market Size & Forecasts by Method (2022–2032)
5.1. Segment Dashboard
5.2. On-pump Devices: Revenue Trend Analysis, 2022 & 2032
5.3. Off-pump Devices: Revenue Trend Analysis, 2022 & 2032
5.4. Minimally Invasive Direct Devices: Revenue Trend Analysis, 2022 & 2032
Chapter 6. Global Coronary Artery Bypass Graft Devices Market Size & Forecasts by Surgical Procedure (2022–2032)
6.1. Segment Dashboard
6.2. Single Vascular Graft, 2022 & 2032
6.3. Double Vascular Graft, 2022 & 2032
6.4. Triple Vascular Graft, 2022 & 2032
6.5. Quadruple Vascular Graft, 2022 & 2032
Chapter 7. Global Coronary Artery Bypass Graft Devices Market Size & Forecasts by End-use (2022–2032)
7.1. Segment Dashboard
7.2. Hospitals, 2022 & 2032
7.3. Ambulatory Surgical Centers, 2022 & 2032
7.4. Cardiac Specialty Clinics, 2022 & 2032
Chapter 8. Global Coronary Artery Bypass Graft Devices Market Size & Forecasts by Region (2022–2032)
8.1. North America Market
?8.1.1. U.S. Market
?8.1.2. Canada Market
8.2. Europe Market
?8.2.1. UK Market
?8.2.2. Germany Market
?8.2.3. France Market
?8.2.4. Spain Market
?8.2.5. Italy Market
?8.2.6. Rest of Europe Market
8.3. Asia Pacific Market
?8.3.1. China Market
?8.3.2. India Market
?8.3.3. Japan Market
?8.3.4. Australia Market
?8.3.5. South Korea Market
?8.3.6. Rest of Asia Pacific Market
8.4. Latin America Market
?8.4.1. Brazil Market
?8.4.2. Mexico Market
?8.4.3. Rest of Latin America Market
8.5. Middle East & Africa Market
?8.5.1. Saudi Arabia Market
?8.5.2. South Africa Market
?8.5.3. Rest of Middle East & Africa Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
?9.1.1. Terumo Corporation
?9.1.2. Boston Scientific Corporation
?9.1.3. Getinge AB
9.2. Top Market Strategies
9.3. Company Profiles
?9.3.1. Terumo Corporation
??9.3.1.1. Key Information
??9.3.1.2. Overview
??9.3.1.3. Financial (Subject to Data Availability)
??9.3.1.4. Product Summary
??9.3.1.5. Market Strategies
?9.3.2. Boston Scientific Corporation
?9.3.3. Getinge AB
?9.3.4. Medtronic plc
?9.3.5. Edwards Lifesciences Corporation
?9.3.6. Genesee BioMedical Inc.
?9.3.7. Sorin Group (LivaNova PLC)
?9.3.8. Novadaq Technologies Inc.
?9.3.9. MAQUET Holding B.V. & Co. KG
?9.3.10. SyntheMed, Inc.
?9.3.11. Vital Therapies, Inc.
?9.3.12. Hancock Jaffe Laboratories Inc.
?9.3.13. Dextera Surgical Inc.
?9.3.14. Baxter International Inc.
?9.3.15. BioStable Science & Engineering Inc.
Chapter 10. Research Process
10.1. Data Mining
10.2. Analysis
10.3. Market Estimation
10.4. Validation
10.5. Publishing
10.6. Research Attributes



List of Figures

List of Figures
FIG 1. Research Methodology Flowchart
FIG 2. Market Estimation Techniques
FIG 3. Global Market Size: Historical vs. Forecast
FIG 4. Key Trends Influencing the Market
FIG 5. CAGR Outlook by Segment (2024–2032)
FIG 6. Porter’s Five Forces Analysis
FIG 7. PESTEL Analysis Summary
FIG 8. Value Chain Analysis
FIG 9. Market Share by Method (2023)
FIG 10. Market Share by Surgical Procedure (2023)
FIG 11. Market Share by End-use (2023)
FIG 12. Regional Snapshot: 2022 vs. 2032
FIG 13. North America Market Trend (2022–2032)
FIG 14. Europe Market Trend (2022–2032)
FIG 15. Asia Pacific Market Trend (2022–2032)
FIG 16. Latin America Market Trend (2022–2032)
FIG 17. Middle East & Africa Market Trend (2022–2032)
FIG 18. Competitive Positioning Map
FIG 19. Forecasted Impact of Emerging Technologies
FIG 20. Surgeon Adoption Intentions by Region (2023)

List of Tables

List of Tables
TABLE 1. Global Coronary Artery Bypass Graft Devices Market, Report Scope
TABLE 2. Global Market Estimates & Forecasts by Region (2022–2032)
TABLE 3. Global Market Estimates & Forecasts by Method (2022–2032)
TABLE 4. Global Market Estimates & Forecasts by Surgical Procedure (2022–2032)
TABLE 5. Global Market Estimates & Forecasts by End-use (2022–2032)
TABLE 6. North America Market Estimates & Forecasts, 2022–2032
TABLE 7. U.S. Market Estimates & Forecasts by Segment, 2022–2032
TABLE 8. Canada Market Estimates & Forecasts by Segment, 2022–2032
TABLE 9. Europe Market Estimates & Forecasts, 2022–2032
TABLE 10. Asia Pacific Market Estimates & Forecasts, 2022–2032
TABLE 11. Latin America Market Estimates & Forecasts, 2022–2032
TABLE 12. Middle East & Africa Market Estimates & Forecasts, 2022–2032
TABLE 13. Competitive Landscape: Market Shares of Top 10 Companies (2023)
TABLE 14. R&D Expenditure by Leading Players (2022)
TABLE 15. Device Adoption Rates by Method (2023)
TABLE 16. Average Surgical Outcomes by Procedure Type (2023)
TABLE 17. Reimbursement Rates Across Major Markets (2023)
TABLE 18. Hospital vs. ASC Utilization Trends (2022–2023)
TABLE 19. Surgeon Training & Credentialing Statistics (2023)
TABLE 20. Forecasted Impact of AI Integration on Market Growth